3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
pembrolizumab
220
Carboplatin
219
Specimen Handling
197
Cisplatin
188
Magnetic Resonance Spectroscopy
166
Radiotherapy
152
Bevacizumab
143
Gemcitabine
135
Cyclophosphamide
134
Drug Therapy
118
Capecitabine
118
Paclitaxel
113
Oxaliplatin
110
Biopsy
105
venetoclax
102
Nivolumab
102
Rituximab
83
tislelizumab
81
durvalumab
81
toripalimab
77
Fluorouracil
73
Etoposide
73
Dexamethasone
69
sintilimab
67
Radiosurgery
67
Docetaxel
67
Pemetrexed
65
atezolizumab
64
Azacitidine
63
Injections
62
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Recruiting
×
AIEOP acute lymphoblastic leukemia protocol
×
Clear all
NCT06184009
2025-06-08
HR ALL
Seoul St. Mary's Hospital
Phase 2
Recruiting
370 enrolled